NextPlat Corp. (NASDAQ:NXPL) Short Interest Update

NextPlat Corp. (NASDAQ:NXPL) was the recipient of a significant decline in short interest during the month of December. As of December 31st, there was short interest totaling 146,349 shares, a decline of 26.5% from the December 15th total of 199,110 shares. Currently, 1.0% of the company’s stock are sold short. Based on an average trading volume of 168,401 shares, the days-to-cover ratio is presently 0.9 days. Based on an average trading volume of 168,401 shares, the days-to-cover ratio is presently 0.9 days. Currently, 1.0% of the company’s stock are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, NextPlat presently has a consensus rating of “Sell”.

Institutional Investors Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC acquired a new position in NextPlat Corp. (NASDAQ:NXPL) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat at the end of the most recent quarter. Hedge funds and other institutional investors own 1.30% of the company’s stock.

NextPlat Stock Performance

NextPlat stock traded up $0.01 on Friday, reaching $0.73. 30,287 shares of the stock were exchanged, compared to its average volume of 129,326. The company has a current ratio of 3.56, a quick ratio of 2.80 and a debt-to-equity ratio of 0.04. NextPlat has a twelve month low of $0.43 and a twelve month high of $1.35. The firm has a fifty day moving average price of $0.63 and a two-hundred day moving average price of $0.73. The stock has a market cap of $19.21 million, a PE ratio of -2.43 and a beta of 1.15.

NextPlat (NASDAQ:NXPL) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($0.08) EPS for the quarter. NextPlat had a negative return on equity of 34.22% and a negative net margin of 14.58%.The business had revenue of $13.75 million during the quarter.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.